BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1892120)

  • 1. Lactic dehydrogenase. An old enzyme reborn as a cancer marker?
    Schwartz MK
    Am J Clin Pathol; 1991 Oct; 96(4):441-3. PubMed ID: 1892120
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate dehydrogenase isoenzyme 1 activity in sera of patients with ovarian cancer.
    Buamah PK; Skillen AW
    Clin Chem; 1990 Apr; 36(4):707-8. PubMed ID: 2323059
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactate dehydrogenase should be used as marker in testicular tumours.
    Hughes O; Bishop M
    BMJ; 1996 Sep; 313(7057):625. PubMed ID: 8806267
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatomyositis associated with testicular tumour with elevation of serum lactate dehydrogenase (LDH) isoenzyme-1.
    Ishizawa T; Mitsuhashi Y; Kondo S
    Acta Derm Venereol; 1999 Mar; 79(2):167. PubMed ID: 10228646
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysgerminoma in mother and daughter: use of lactate dehydrogenase as a tumor marker in the child.
    Chisholm JC; Darmady JM; Kohler JA
    Pediatr Hematol Oncol; 1995; 12(3):305-8. PubMed ID: 7640186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyl transferase: risk and prognosis of cancer.
    Fentiman IS
    Br J Cancer; 2012 Apr; 106(9):1467-8. PubMed ID: 22531718
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum lactic dehydrogenase activity and lactic dehydrogenase isoenzymes pattern in oral cancer patients--a diagnostic aid.
    Jina RP; Jina R; Rai SP
    Uttar Pradesh State Dent J; 1979 Sep; 10(3):69-70, 77. PubMed ID: 298704
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
    Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDH in the follow-up of stage I malignant melanoma.
    Campora E; Repetto L; Giuntini P; Bertelli G; Amoroso D; Sertoli MR; Rosso R
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):277-8. PubMed ID: 3356214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patterns of serum lactic dehydrogenase (EC,1.1.1.27) isoenzymes in the diagnosis of primary and metastatic neoplasms of the liver].
    Wieckowski B
    Pol Tyg Lek; 1972 Jul; 27(28):1073-5. PubMed ID: 5069437
    [No Abstract]   [Full Text] [Related]  

  • 14. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
    de Lecea MV; Palomares T; Al Kassam D; Cavia M; Geh JLC; de Llano P; Muñiz P; Armesto D; Martinez-Indart L; Alonso-Varona A
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):636-642. PubMed ID: 27633490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on lactic dehydrogenase, lactic dehydrogenase isoenzymes and aldolase in human leukemias and on mechanism of those enzyme elevation.
    Kamiya T
    Nagoya Med J; 1970 Jul; 16(1):15-39. PubMed ID: 5458427
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lactic dehydrogenase and primary carcinoma of the ovary.
    Younis JS; Zeevi D; Hadani PE; Anteby SO
    Gynecol Obstet Invest; 1989; 28(1):47-50. PubMed ID: 2777134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum 5-S-cysteinyl-dopa as a biomarker for predicting prognosis and detecting relapse in patients with advanced stage malignant melanoma.
    Umemura H; Yamasaki O; Kaji T; Otsuka M; Asagoe K; Takata M; Iwatsuki K
    J Dermatol; 2017 Apr; 44(4):449-454. PubMed ID: 27786364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum markers for melanoma].
    Ugurel S
    Hautarzt; 2005 Feb; 56(2):173-84; 185-6. PubMed ID: 15657726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cellulose acetate gel (Cellogel) for the demonstration of lactic dehydrogenase isoenzymes.
    Warburton FG; Waddecar J
    J Clin Pathol; 1966 Sep; 19(5):517-9. PubMed ID: 5919369
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lactic dehydrogenase and its isoenzymes in myocardial infarction.
    Ramdeo IN; Andleigh HS; Joshi KC
    Indian J Med Res; 1969 Jun; 57(6):1037-44. PubMed ID: 5823168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.